149 related articles for article (PubMed ID: 10871979)
21. The response to the first dose of an angiotensin converting enzyme inhibitor in uncomplicated hypertension--a placebo controlled study utilising ambulatory blood pressure recording.
MacFadyen RJ; Bainbridge AD; Lees KR; Reid JL
Br J Clin Pharmacol; 1991 Sep; 32(3):393-8. PubMed ID: 1777377
[TBL] [Abstract][Full Text] [Related]
22. Long-term safety and efficacy of moexipril alone and in combination with hydrochlorothiazide in elderly patients with hypertension.
White WB; Stimpel M
J Hum Hypertens; 1995 Nov; 9(11):879-84. PubMed ID: 8583466
[TBL] [Abstract][Full Text] [Related]
23. [A comparative study of the effects of lisinopril and quinapril administered once a day in essential hypertension].
De Cesaris R; Ranieri G; Andriani A; Chiarappa R
Minerva Med; 1990; 81(7-8):541-6. PubMed ID: 2166253
[TBL] [Abstract][Full Text] [Related]
24. The safety and tolerability of quinapril.
Knapp LE; Frank GJ; McLain R; Rieger MM; Posvar E; Singer R
J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S47-55. PubMed ID: 1691407
[TBL] [Abstract][Full Text] [Related]
25. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
Sedman AJ; Posvar E
Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762
[TBL] [Abstract][Full Text] [Related]
26. Use of quinapril in the elderly patient.
Schnaper HW
Am J Hypertens; 1990 Nov; 3(11):278S-282S. PubMed ID: 2261146
[TBL] [Abstract][Full Text] [Related]
27. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
Tytus RH; Burgess ED; Assouline L; Vanjaka A
Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
[TBL] [Abstract][Full Text] [Related]
28. [Conversion from oral ACE inhibitor to intravenous quinaprilat administration in mild to moderate essential hypertension].
Schmidt BM; Smilde J; Oldenbroek C; Wehling M
Med Klin (Munich); 1998 Dec; 93(12):701-6. PubMed ID: 10024837
[TBL] [Abstract][Full Text] [Related]
29. Can an angiotensin-converting enzyme inhibitor with a short half-life effectively lower blood pressure for 24 hours?
Palatini P
Am Heart J; 1992 May; 123(5):1421-5. PubMed ID: 1575169
[TBL] [Abstract][Full Text] [Related]
30. Effect of losartan on nocturnal blood pressure in patients with stroke: comparison with angiotensin converting enzyme inhibitor.
Okuguchi T; Osanai T; Fujiwara N; Kato T; Metoki N; Konta Y; Okumura K
Am J Hypertens; 2002 Nov; 15(11):998-1002. PubMed ID: 12441222
[TBL] [Abstract][Full Text] [Related]
31. Antihypertensive effectiveness of a very low fixed-dose combination of moexipril and hydrochlorothiazide.
Chrysant SG; Stimpel M
J Cardiovasc Pharmacol; 1998 Mar; 31(3):384-90. PubMed ID: 9514183
[TBL] [Abstract][Full Text] [Related]
32. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
Plosker GL; Sorkin EM
Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the efficacy and safety of quinapril vs. captopril in treatment of moderate to severe hypertension.
Schnaper HW
Angiology; 1989 Apr; 40(4 Pt 2):389-95. PubMed ID: 2650582
[TBL] [Abstract][Full Text] [Related]
34. [A comparative study of the efficacy of lisinopril versus quinapril in controlling light to moderate arterial hypertension. A follow-up with ABPM].
Motero Carrasco J
Rev Esp Cardiol; 1995 Nov; 48(11):746-53. PubMed ID: 8532944
[TBL] [Abstract][Full Text] [Related]
35. Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors.
Puig JG; Mateos FA; Ramos TH; Lavilla MP; Capitán MC; Gil A
Am J Hypertens; 1994 Jan; 7(1):46-51. PubMed ID: 8136110
[TBL] [Abstract][Full Text] [Related]
36. Quinapril hydrochloride effects on renal function in patients with renal dysfunction and hypertension: a drug-withdrawal study.
Miller MA; Texter M; Gmerek A; Robbins J; Shurzinske L; Canter D
Cardiovasc Drugs Ther; 1994 Apr; 8(2):271-5. PubMed ID: 7918140
[TBL] [Abstract][Full Text] [Related]
37. Effect of quinapril on blood pressure and heart rate in congestive heart failure.
Townend JN; West JN; Davies MK; Littler WA
Am J Cardiol; 1992 Jun; 69(19):1587-90. PubMed ID: 1598874
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of quinapril in the elderly hypertensive patient.
Forette B; Koen R; Vicaut E
Am Heart J; 1992 May; 123(5):1426-32. PubMed ID: 1575170
[TBL] [Abstract][Full Text] [Related]
39. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
White WB; Lacourciere Y; Davidai G
Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
[TBL] [Abstract][Full Text] [Related]
40. Speed and duration of dose titration with the angiotensin converting enzyme inhibitor quinapril: relationship with efficacy in patients with moderate hypertension.
Weir MR
J Hum Hypertens; 1994 Sep; 8(9):725-30. PubMed ID: 7807504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
